Details for Patent: 9,968,553

Which drugs does patent 9,968,553 protect, and when does it expire?

Patent 9,968,553 protects EPANED KIT and is included in one NDA.

This patent has five patent family members in five countries.

Summary for Patent: 9,968,553

Title:	Enalapril compositions
Abstract:	Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
Inventor(s):	Rajewski; Lian G. (Lawrence, KS), Rajewski; Roger A. (Lawrence, KS), Haslam; John L. (Lawrence, KS), Heppert; Kathleen (Lawrence, KS), Beckloff; Michael C. (Leawood, KS), Segrave; Frank (Dublin, OH), Mauro; Robert (Miller Place, NY), Colabuono; Peter (Las Vegas, NV)
Assignee:	SILVERGATE PHARMACAUTICALS, INC. (Greenwood Village, CO) UNIVERSITY OF KANSAS (Lawrence, KS)
Application Number:	15/850,732
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,968,553
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 9,968,553

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Silvergate Pharms	EPANED KIT	enalapril maleate	FOR SOLUTION;ORAL	204308-001	Aug 13, 2013		DISCN	Yes	No						METHOD OF TREATMENT OF HEART FAILURE
Silvergate Pharms	EPANED KIT	enalapril maleate	FOR SOLUTION;ORAL	204308-001	Aug 13, 2013		DISCN	Yes	No						TREATMENT OF HYPERTENSION
Silvergate Pharms	EPANED KIT	enalapril maleate	FOR SOLUTION;ORAL	204308-001	Aug 13, 2013		DISCN	Yes	No						METHOD OF TREATING LEFT VENTRICULAR DYSFUNCTION
Silvergate Pharms	EPANED KIT	enalapril maleate	FOR SOLUTION;ORAL	204308-001	Aug 13, 2013		DISCN	Yes	No						METHOD OF TREATING HYPERTENSION

International Family Members for US Patent 9,968,553

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Brazil	112015007592
Canada	2887379
European Patent Office	2903690
Spain	2770403